Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1379128

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1379128

Inhaled Nitric Oxide Market Report by Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), and Others), and Region 2023-2028

PUBLISHED:
PAGES: 140 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2499
PDF & Excel (5 User License)
USD 3499
PDF & Excel (Corporate License)
USD 4499

Add to Cart

Abstract

The global inhaled nitric oxide market size reached US$ 877.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,361.1 Million by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2022-2028.

Inhaled nitric oxide (iNO) refers to a selective pulmonary vasodilator supervised by skilled physicians at tertiary neonatal intensive care units (NICUs). It assists in regulating vascular muscle tone and treating hypoxemic respiratory failure among newly born infants by improving ventilation-perfusion mismatch and reducing elevated pulmonary vascular resistance and hypertension. It also aids in improving oxygenation and decreasing the need for extracorporeal membrane oxygenation (ECMO). At present, there is a rise in the use of iNO therapy as a rescue agent for acute respiratory distress syndrome (ARDS) patients.

Inhaled Nitric Oxide Market Trends:

The increasing prevalence of respiratory and other subsequent diseases in newborns, such as persistent pulmonary hypertension and neonatal hypoxic respiratory failure (HRF), represents one of the primary factors significantly contributing to the market growth. Additionally, the rising geriatric population, which is relatively more prone to hypertension, atherosclerosis, peripheral artery disease, heart failure, and thrombosis, is supporting the growth of the market. Furthermore, iNO is gaining immense traction worldwide for treating chronic obstructive pulmonary diseases (COPD), asthma, and ARDS. Moreover, the outbreak of the highly contagious coronavirus disease (COVID-19) and an alarmingly increasing number of individuals getting infected on a global level are favorably influencing the market. Furthermore, iNO therapy is being used against coronavirus stains as it assists in improving ventilation/perfusion in patients with severe pneumonia. The market is also driven by the ongoing research and development (R&D) activities in the healthcare industry around the world to improve the overall patient experience.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global inhaled nitric oxide market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on application.

Breakup by Application:

Neonatal Respiratory Treatment

Chronic Obstructive Pulmonary Disease (COPD)

Acute Respiratory Distress Syndrome (ARDS)

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Air Liquide S.A, Bellerophon Therapeutics, Beyond Air Inc., Linde plc, Mallinckrodt plc, Merck KGaA, Novoteris LLC, Nu-Med Plus and VERO Biotech LLC.

Key Questions Answered in This Report:

  • How has the global inhaled nitric oxide market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global inhaled nitric oxide market?
  • What are the key regional markets?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global inhaled nitric oxide market and who are the key players?
  • What is the degree of competition in the industry?
Product Code: SR112023A4100

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Inhaled Nitric Oxide Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Neonatal Respiratory Treatment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Acute Respiratory Distress Syndrome (ARDS)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Region

  • 7.1 North America
    • 7.1.1 United States
      • 7.1.1.1 Market Trends
      • 7.1.1.2 Market Forecast
    • 7.1.2 Canada
      • 7.1.2.1 Market Trends
      • 7.1.2.2 Market Forecast
  • 7.2 Asia-Pacific
    • 7.2.1 China
      • 7.2.1.1 Market Trends
      • 7.2.1.2 Market Forecast
    • 7.2.2 Japan
      • 7.2.2.1 Market Trends
      • 7.2.2.2 Market Forecast
    • 7.2.3 India
      • 7.2.3.1 Market Trends
      • 7.2.3.2 Market Forecast
    • 7.2.4 South Korea
      • 7.2.4.1 Market Trends
      • 7.2.4.2 Market Forecast
    • 7.2.5 Australia
      • 7.2.5.1 Market Trends
      • 7.2.5.2 Market Forecast
    • 7.2.6 Indonesia
      • 7.2.6.1 Market Trends
      • 7.2.6.2 Market Forecast
    • 7.2.7 Others
      • 7.2.7.1 Market Trends
      • 7.2.7.2 Market Forecast
  • 7.3 Europe
    • 7.3.1 Germany
      • 7.3.1.1 Market Trends
      • 7.3.1.2 Market Forecast
    • 7.3.2 France
      • 7.3.2.1 Market Trends
      • 7.3.2.2 Market Forecast
    • 7.3.3 United Kingdom
      • 7.3.3.1 Market Trends
      • 7.3.3.2 Market Forecast
    • 7.3.4 Italy
      • 7.3.4.1 Market Trends
      • 7.3.4.2 Market Forecast
    • 7.3.5 Spain
      • 7.3.5.1 Market Trends
      • 7.3.5.2 Market Forecast
    • 7.3.6 Russia
      • 7.3.6.1 Market Trends
      • 7.3.6.2 Market Forecast
    • 7.3.7 Others
      • 7.3.7.1 Market Trends
      • 7.3.7.2 Market Forecast
  • 7.4 Latin America
    • 7.4.1 Brazil
      • 7.4.1.1 Market Trends
      • 7.4.1.2 Market Forecast
    • 7.4.2 Mexico
      • 7.4.2.1 Market Trends
      • 7.4.2.2 Market Forecast
    • 7.4.3 Others
      • 7.4.3.1 Market Trends
      • 7.4.3.2 Market Forecast
  • 7.5 Middle East and Africa
    • 7.5.1 Market Trends
    • 7.5.2 Market Breakup by Country
    • 7.5.3 Market Forecast

8 SWOT Analysis

  • 8.1 Overview
  • 8.2 Strengths
  • 8.3 Weaknesses
  • 8.4 Opportunities
  • 8.5 Threats

9 Value Chain Analysis

10 Porters Five Forces Analysis

  • 10.1 Overview
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Degree of Competition
  • 10.5 Threat of New Entrants
  • 10.6 Threat of Substitutes

11 Price Analysis

12 Competitive Landscape

  • 12.1 Market Structure
  • 12.2 Key Players
  • 12.3 Profiles of Key Players
    • 12.3.1 Air Liquide S.A
      • 12.3.1.1 Company Overview
      • 12.3.1.2 Product Portfolio
      • 12.3.1.3 Financials
      • 12.3.1.4 SWOT Analysis
    • 12.3.2 Bellerophon Therapeutics
      • 12.3.2.1 Company Overview
      • 12.3.2.2 Product Portfolio
      • 12.3.2.3 Financials
    • 12.3.3 Beyond Air Inc.
      • 12.3.3.1 Company Overview
      • 12.3.3.2 Product Portfolio
      • 12.3.3.3 Financials
    • 12.3.4 Linde plc
      • 12.3.4.1 Company Overview
      • 12.3.4.2 Product Portfolio
      • 12.3.4.3 Financials
    • 12.3.5 Mallinckrodt plc
      • 12.3.5.1 Company Overview
      • 12.3.5.2 Product Portfolio
      • 12.3.5.3 Financials
    • 12.3.6 Merck KGaA
      • 12.3.6.1 Company Overview
      • 12.3.6.2 Product Portfolio
      • 12.3.6.3 Financials
      • 12.3.6.4 SWOT Analysis
    • 12.3.7 Novoteris LLC
      • 12.3.7.1 Company Overview
      • 12.3.7.2 Product Portfolio
    • 12.3.8 Nu-Med Plus
      • 12.3.8.1 Company Overview
      • 12.3.8.2 Product Portfolio
      • 12.3.8.3 Financials
    • 12.3.9 VERO Biotech LLC
      • 12.3.9.1 Company Overview
      • 12.3.9.2 Product Portfolio
Product Code: SR112023A4100

List of Figures

  • Figure 1: Global: Inhaled Nitric Oxide Market: Major Drivers and Challenges
  • Figure 2: Global: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Inhaled Nitric Oxide Market: Breakup by Application (in %), 2022
  • Figure 5: Global: Inhaled Nitric Oxide Market: Breakup by Region (in %), 2022
  • Figure 6: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 7: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 8: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome (ARDS)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome (ARDS)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Inhaled Nitric Oxide (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Inhaled Nitric Oxide (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: North America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: North America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: United States: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: United States: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Canada: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Canada: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Asia-Pacific: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Asia-Pacific: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: China: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: China: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Japan: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Japan: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: India: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: India: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: South Korea: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: South Korea: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Australia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Australia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Indonesia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Indonesia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Europe: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Europe: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Germany: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Germany: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: France: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: France: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United Kingdom: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United Kingdom: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Italy: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Italy: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Spain: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Spain: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Russia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Russia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Latin America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Latin America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Brazil: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Brazil: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Mexico: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Mexico: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Middle East and Africa: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Middle East and Africa: Inhaled Nitric Oxide Market: Breakup by Country (in %), 2022
  • Figure 62: Middle East and Africa: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Global: Inhaled Nitric Oxide Industry: SWOT Analysis
  • Figure 64: Global: Inhaled Nitric Oxide Industry: Value Chain Analysis
  • Figure 65: Global: Inhaled Nitric Oxide Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Inhaled Nitric Oxide Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Inhaled Nitric Oxide Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 3: Global: Inhaled Nitric Oxide Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 4: Global: Inhaled Nitric Oxide Market: Competitive Structure
  • Table 5: Global: Inhaled Nitric Oxide Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!